centile) among women booked under hospital care with singleton, non-anomalous pregnancy was compared between 2012 (pre-GAP, n=1105) and 2017 (post-GAP, n=1080). Analyses were adjusted for maternal age, BMI, deprivation, smoking and ethnicity.
Results: SGA rates were similar across epochs (13.8% vs 12.9%, P = 0.8) but antenatal detection of SGA increased from 22.9% (33/153) to 57.9% (81/140) after introduction of GAP (aOR 4.78, 95%CI 2.78, 8.21 ). Rates of induction of labour and caesarean section increased between epochs (28.2% vs 34.0%, and 31.5% vs 36.5%, respectively) but increases were similar among SGA and non-SGA (P ≥ 0.2), and detected and nondetected SGA (P≥0.8). Among SGA babies, antenatal detection of SGA tended to be associated with reduced neonatal admission >48 h post-GAP [detected aOR 0.43 (0.16,1.19)]; non-detected aOR 1. 48 [0.49,4 .51]; P = 0.1). Preterm birth, low Apgar and neonatal respiratory support did not appear to be influenced by GAP.
Conclusions: Implementation of GAP in this multiethnic population with high obesity was associated with a 4-fold increase in likelihood of SGA detection without increasing obstetric intervention for SGA. Research Clayton, Victoria, Australia Background: There is increasing evidence that placental mitochondrial dysfunction significantly contributes to the excessive oxidative stress that underlies preeclampsia. An agent that could improve mitochondrial function may offer new opportunities for the prevention and/or treatment of preeclampsia. Sulforaphane (SFN) is a naturally occurring antioxidant that may be such an agent.
INVESTIGATING THE EFFECT
Methods: Placental cytotrophoblasts were isolated from healthy term placentae (n = 5) and incubated for 48 h in 8% O 2 AE 1 μM SFN before hypoxic injury (24 h 1% O 2 ). Cells were stained with mitotracker red, and imaged using confocal microscopy for 1hr, with reduced dye uptake indicative of mitochondrial dysfunction. MTS cell proliferation assay was performed to assess viability after treatment with SFN in hypoxia and normoxia. Mitochondrial respiration was assessed using the Seahorse MitoStress XF assay (Agilent).
Results: Statistical analysis was performed using two-way ANOVA for respiration and imaging, and one-way ANOVA for MTS assay. Hypoxia decreased mitochondrial maximal respiration (P = 0.03) and spare respiratory capacity (P=0.03). Compared to control, 1μM SFN significantly improved maximum respiration (P = 0.01), ATP production (P = 0.04) and spare respiratory capacity (P = 0.03) after hypoxic injury. Live imaging showed that hypoxia-induced impairment of mitochondrial dye uptake (P = 0.02) was prevented by 1μM SFN (P = 0.02). Compared to control, SFN 1μM had higher viability in both hypoxic (P = 0.02) and normoxic (P = 0.01) conditions.
Conclusion: SFN appears to be able to rescue hypoxiainduced mitochondrial dysfunction in cultured placental cells. Further investigation into the effects of other placental injury, including hyperoxic injury, is warranted.
DOES BLOOD DONOR SEX INFLUENCE TRANSFUSION-RELATED OUTCOMES IN PRETERM NEWBORNS?
Crawford Red blood cell (RBC) transfusions are associated with increased rates of neonatal morbidities likely secondary to inflammatory responses to transfusion. Recently, attention has focused on donor characteristics including sex, with disproportionately increased rates of morbidity and mortality in patients exposed to female donors' blood. This study investigated the association between rates of significant neonatal morbidities and RBC donor sex in preterm newborns.
Methods: The study population comprised newborns <28 +6 weeks gestation (n = 70) receiving their first transfusion. Transfusion pack and donation number were recorded to allow reidentification donor sex. Comparisons were made between newborns of either sex who received male and female blood (n = 51) versus those who received only male blood (n =15). Logistic and linear regression models were used to investigate the effect of female donor blood exposure.
Results: In univariate analysis, compared to newborns who received only male blood, infants who received any female blood had higher rates of bronchopulmonary dysplasia, any morbidity, and length of ventilation and hospital stay (P < 0.01). In adjusted analysis, female blood was associated with increased risk of BPD (P < 0.05) and length of stay (P < 0.05).
